Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune

Xianzhen Hu1, Scott R Barnum1, Jillian E Wohler1

  • 1Department of Microbiology University of Alabama at Birmingham, Birmingham, AL, USA 35294.

Molecular Immunology
|April 8, 2010
PubMed

Insights

Alternative splicing of Intercellular adhesion molecule-1 (ICAM-1) produces functional isoforms. These isoforms significantly impact experimental autoimmune encephalomyelitis (EAE) severity and T cell responses, suggesting roles in multiple sclerosis.

Area of Science:

  • Immunology
  • Neuroscience
  • Molecular Biology

Background:

  • Intercellular adhesion molecule-1 (ICAM-1) is crucial for leukocyte function and immune responses.
  • ICAM-1, part of the immunoglobulin superfamily, exhibits alternative splicing, generating diverse protein isoforms.
  • Limited functional data exists for ICAM-1 isoforms, particularly their expression and ligand interactions.

Purpose of the Study:

  • To investigate the functional significance of alternatively spliced ICAM-1 isoforms in vivo.
  • To determine the impact of specific ICAM-1 isoforms on the disease course of experimental autoimmune encephalomyelitis (EAE).
  • To explore the role of ICAM-1 isoforms in T cell activation and cytokine production.

Main Methods:

  • Utilized two distinct lines of mutant mice (Icam1(tm1Jcgr) and Icam1(tm1Bay)) with altered ICAM-1 isoform expression.
  • Assessed disease severity and progression in models of EAE.
  • Analyzed T cell proliferation kinetics and interferon-gamma (IFN-gamma) production.

Main Results:

  • Mutant mice lacking Mac-1 binding isoforms (Icam1(tm1Jcgr)) exhibited significantly attenuated EAE.
  • Mice expressing specific isoforms (Icam1(tm1Bay)) showed severe EAE, increased T cell proliferation, and higher IFN-gamma levels compared to wild-type and Icam1(tm1Jcgr) mice.
  • Demonstrated that alternatively spliced ICAM-1 isoforms are functional and influence EAE pathogenesis.

Conclusions:

  • Alternatively spliced ICAM-1 isoforms play critical roles in central nervous system (CNS) inflammation and demyelination during EAE.
  • These findings suggest ICAM-1 isoforms may be therapeutic targets for inflammatory diseases like multiple sclerosis.
  • Differential engagement of ICAM-1 ligands, such as Mac-1, by specific isoforms likely mediates their functional effects.